Genetic Skin Disease (EB): Optimizing Embryonic Stem Cell Differentiation Protocols

Posted: September 12, 2011 at 12:06 pm



(Part 6 of 6) Anthony Oro, MD, Ph.D., spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the CIRM Governing Board meeting on February 4, 2010. Oro is an associate professor of dermatology in the Stanford School of Medicine. He is a co-principal investigator on the CIRM Disease Team that is developing a stem cell-based therapy for epidermolysis bullosa.

Read the original:
Genetic Skin Disease (EB): Optimizing Embryonic Stem Cell Differentiation Protocols

Related Post

Comments are closed.

Archives